Kennett Sprogøe

19 Patents

• US125655252026

  IL-2 Conjugates

  ASCENDIS PHARMA ONCOLOGY DIVISION A/S

  0 cites
• US125444282026

  Controlled-release CNP Agonists with Reduced Side-effects

  ASCENDIS PHARMA GROWTH DISORDERS A/S

  0 cites
• US124537782025

  Incremental Dose Finding in Controlled-release PTH Compounds

  ASCENDIS PHARMA BONE DISEASES A/S

  0 cites
• US124031822025

  Liquid Pharmaceutical Formulations of PTH Conjugates

  ASCENDIS PHARMA BONE DISEASES A/S

  0 cites
• US123035532025

  Long-acting Growth Hormone Dosage Forms with Superior Efficacy to Daily Somatropin

  ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S

  0 cites
• US122959892025

  Controlled-release PTH Compound

  ASCENDIS PHARMA BONE DISEASES A/S

  0 cites
• US122747372025

  Pegylated Recombinant Human Growth Hormone Compounds

  Ascendis Pharma Endocrinology Division A/S

  0 cites
• US122396892025

  Controlled-release CNP Agonists with Low Initial NPR-B Activity

  ASCENDIS PHARMA GROWTH DISORDERS A/S

  0 cites
• US122140202025

  PTH Prodrugs

  ASCENDIS PHARMA BONE DISEASES A/S

  0 cites
• US121569172024

  CNP Prodrugs with Carrier Attachment at the Ring Moiety

  ASCENDIS PHARMA GROWTH DISORDERS A/S

  0 cites
• US120831822024

  Controlled-release CNP Agonists with Increased NEP Stability

  ASCENDIS PHARMA GROWTH DISORDERS A/S

  0 cites
• US120169032024

  Long-acting Growth Hormone Treatment

  ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S

  0 cites
• US119186282024

  Controlled-release PTH Compound

  ASCENDIS PHARMA BONE DISEASES A/S

  0 cites
• US118903262024

  Controlled-release PTH Compound

  ASCENDIS PHARMA BONE DISEASES A/S

  0 cites
• US118576032024

  PTH Compounds with Low Peak-to-trough Ratios

  ASCENDIS PHARMA BONE DISEASES A/S

  0 cites
• US117938612023

  PTH Prodrugs

  ASCENDIS PHARMA BONE DISEASES A/S

  0 cites
• US117595042023

  PTH Compounds with Low Peak-to-trough Ratios

  Ascendis Pharma Bone Diseases A/S

  0 cites
• US115902072023

  Dosage Regimen for a Controlled-release PTH Compound

  ASCENDIS PHARMA BONE DISEASES A/S

  0 cites
• US115649742023

  Combination Therapy with Controlled-release CNP Agonists

  ASCENDIS PHARMA GROWTH DISORDERS A/S

  0 cites